Back to results
US 2020/0206339 A1Published application
Recombinant viral vector systems expressing exogenous feline paramyxovirus genes and vaccines made therefrom
AssigneesBoehringer Ingelheim Vetmedica GmbH, Boehringer Ingelheim Animal Health USA Inc.
InventorsHervé POULET, Veljko NIKOLIN, Abraham Johannes DE SMIT, Teshome MEBATSION
Life of this patent
Estimating the term…
Abstract
The present invention relates to exogenous feline paramyxovirus genes, which are expressed from recombinant viral vector systems.
Claims21
A viral vector, preferably a recombinant and/or non-naturally occurring viral vector, comprising at least one exogenous antigen encoding sequence relating to/of at least one pathogen infecting felines, wherein the at least one pathogen infecting felines is feline paramyxovirus.
(canceled)
(canceled)
Dependencies are inferred from the claim text.